Health Trials

Hepatitis B Virus-Related Hepatocellular Carcinoma

2

Review clinical trials related to Hepatitis B Virus-Related Hepatocellular Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

This Phase 1/ 2a study is a multicenter study to evaluate the safety, tolerability and efficacy of SCG101 in subjects with hepatitis B virus-related hepatocellular carcinoma

Participants needed: 46
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: SCG Cell Therapy Pte. Ltd.Updated: Feb 18, 2025Locations: 6
Eligibility criteria

Histologically or cytologically confirmed Hepatocellular carcinoma (HCC) [+9]

Subjects with history of another primary cancer [+8]

Read more
Status: Recruiting

A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related

This is a Phase I clinical study aimed to assess the safety, tolerability, and efficacy of SCG101 monotherapy for patients with HBV-HCC.

Participants needed: 38
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: SCG Cell Therapy Pte. Ltd.Updated: Sep 27, 2024Locations: 7
Eligibility criteria

Histologically or cytologically confirmed Hepatocellular carcinoma (HCC) [+8]

Subjects with history of another primary cancer within 5 years [+10]

Read more